Development of the Liverpool Adverse Drug Reaction Avoidability Assessment Tool

被引:32
作者
Bracken, Louise E. [1 ]
Nunn, Anthony J. [2 ]
Kirkham, Jamie J. [3 ]
Peak, Matthew [1 ,4 ]
Arnott, Janine [1 ]
Smyth, Rosalind L. [5 ]
Pirmohamed, Munir [6 ]
Turner, Mark A. [1 ,2 ,7 ]
机构
[1] Alder Hey Childrens NHS Fdn Trust, Inst Pk, Paediat Med Res Unit, Liverpool, Merseyside, England
[2] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England
[3] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England
[4] Univ Cent Lancashire, Sch Hlth, Preston PR1 2HE, Lancs, England
[5] UCL, Inst Child Hlth, London WC1E 6BT, England
[6] Univ Liverpool, Inst Translat Med, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England
[7] Liverpool Womens NHS Fdn Trust, Liverpool, Merseyside, England
关键词
HOSPITAL ADMISSIONS; PREVENTABILITY; CHILDREN;
D O I
10.1371/journal.pone.0169393
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Aim To develop and test a new tool to assess the avoidability of adverse drug reactions that is suitable for use in paediatrics but which is also applicable to a variety of other settings. Methods The study involved multiple phases. Preliminary work involved using the Hallas scale and a modification of the existing Hallas scale, to assess two different sets of adverse drug reaction (ADR) case reports. Phase 1 defined, modified and refined a new tool using multidisciplinary teams. Phase 2 involved the assessment of 50 ADR case reports from a prospective study of paediatric inpatients by individual assessors. Phase 3 compared assessments with the new tool for individuals and groups in comparison to the 'gold standard' (the avoidability outcome set by a panel of senior investigators: an experienced clinical pharmacologist, paediatrician and pharmacist). Main Outcome Measures Inter-rater reliability (IRR), measure of disagreement and utilization of avoidability categories. Results Preliminary work Pilot phase: results for the original Hallas cases were fair and pairwise kappa scores ranged from 0.21 to 0.36. Results for the modified Hallas cases were poor, pairwise kappa scores ranged from 0.06 to 0.16. Phase 1: on initial use of the new tool, agreement between the two multidisciplinary groups was found on 13/20 cases with a kappa score of 0.29 (95% CI-0.04 to 0.62). Phase 2: the assessment of 50 ADR case reports by six individual reviewers yielded pair wise kappa scores ranging from poor to good 0.12 to 0.75 and percentage exact agreement (%EA) ranged from 52-90%. Phase 3: Percentage exact agreement ranged from 35-70%. Overall, individuals had better agreement with the 'gold standard'. Conclusion Avoidability assessment is feasible but needs careful attention to methods. The Liverpool ADR avoidability assessment tool showed mixed IRR. We have developed and validated a method for assessing the avoidability of ADRs that is transparent, more objective than previous methods and that can be used by individuals or groups.
引用
收藏
页数:11
相关论文
共 20 条
[1]  
Altman D. G., 1990, Practical Statistics for medical research, DOI DOI 10.1201/9780429258589
[2]   AGREE II: advancing guideline development, reporting and evaluation in health care [J].
Brouwers, Melissa C. ;
Kho, Michelle E. ;
Browman, George P. ;
Burgers, Jako S. ;
Cluzeau, Francoise ;
Feder, Gene ;
Fervers, Beatrice ;
Graham, Ian D. ;
Grimshaw, Jeremy ;
Hanna, Steven E. ;
Littlejohns, Peter ;
Makarski, Julie ;
Zitzelsberger, Louise .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2010, 182 (18) :E839-E842
[3]   A pilot randomised controlled trial to assess the utility of an e-learning package that trains users in adverse drug reaction causality [J].
Conroy, Elizabeth J. ;
Kirkham, Jamie J. ;
Bellis, Jennifer R. ;
Peak, Matthew ;
Smyth, Rosalind L. ;
Williamson, Paula R. ;
Pirmohamed, Munir .
INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2015, 23 (06) :447-455
[4]   Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes [J].
Davies, Emma C. ;
Green, Christopher F. ;
Taylor, Stephen ;
Williamson, Paula R. ;
Mottram, David R. ;
Pirmohamed, Munir .
PLOS ONE, 2009, 4 (02)
[5]   Lack of awareness of community-acquired adverse drug reactions upon hospital admission - Dimensions and consequences of a dilemma [J].
Dormann, H ;
Criegee-Rieck, M ;
Neubert, A ;
Egger, T ;
Geise, A ;
Krebs, S ;
Schneider, TH ;
Levy, M ;
Hahn, EG ;
Brune, K .
DRUG SAFETY, 2003, 26 (05) :353-362
[6]   Preventability of Drug-Related Harms - Part I A Systematic Review [J].
Ferner, Robin E. ;
Aronson, Jeffrey K. .
DRUG SAFETY, 2010, 33 (11) :985-994
[7]  
FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619
[8]   Adverse Drug Reactions Causing Admission to a Paediatric Hospital [J].
Gallagher, Ruairi M. ;
Mason, Jennifer R. ;
Bird, Kim A. ;
Kirkham, Jamie J. ;
Peak, Matthew ;
Williamson, Paula R. ;
Nunn, Anthony J. ;
Turner, Mark A. ;
Pirmohamed, Munir ;
Smyth, Rosalind L. .
PLOS ONE, 2012, 7 (12)
[9]   Development and Inter-Rater Reliability of the Liverpool Adverse Drug Reaction Causality Assessment Tool [J].
Gallagher, Ruairi M. ;
Kirkham, Jamie J. ;
Mason, Jennifer R. ;
Bird, Kim A. ;
Williamson, Paula R. ;
Nunn, Anthony J. ;
Turner, Mark A. ;
Smyth, Rosalind L. ;
Pirmohamed, Munir .
PLOS ONE, 2011, 6 (12)
[10]   Percentage of Patients with Preventable Adverse Drug Reactions and Preventability of Adverse Drug Reactions - A Meta-Analysis [J].
Hakkarainen, Katja M. ;
Hedna, Khadidja ;
Petzold, Max ;
Hagg, Staffan .
PLOS ONE, 2012, 7 (03)